RLRyszard Lazny

Ryszard Lazny

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ryszard Lazny has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    C60-Modified Diazonium Cation as a Reactive Agent in Electrochemical Synthesis of Thin Fullerene-Containing Polymeric Films on the Glassy Carbon Electrode

    by Patrycja Wilczewska, Mateusz Pokora, Barbara Seroka, Katarzyna Gdula, Anna Basa, Jakub Goclon, Agata Blacha-Grzechnik, Diana Bobrowska, Ryszard ŁaźnY, Emilia GrądZka, et al.

    The electrochemical reduction of the 4-(4,5-fullero-1-methylpyrrolidin-2-yl)benzenediazonium (C60-pyr-benN2+) cation on glassy carbon electrode (GCE) results in the formation of a fullerene-based polymeric phase (poly-C60-pyr-ben) at the electrode surface. The electrode surface is covalently modified with a monolayer of C60-pyr-ben• radicals. Subsequently, a polymer multilayer is formed through the deposition of electrochemically generated radicals on the fullerene network. There is a significant difference in the energy of C60-pyr-ben• radical bonding to glassy carbon and to the fullerene moiety. The energy involved in the radical bonding to the carbon surface is significantly lower than the energy required to connect the radical to the fullerene network. The amount of material deposited at the electrode surface is controlled by the experimental time window. The morphological, structural, electrochemical, and spectroscopic properties of electrochemically synthesized poly-C60-pyr-ben are investigated. The fullerene-based polymer exhibits reversible electrochemical activity in the negative potential range owing to the redox properties of the C60 moiety.

  • Open Access

    Mechanochemical pyrophosphate bond formation en route to 7-methylguanosine mRNA cap analogs

    by Barbara Seroka, Bartosz Majewski, Michal Sienkiewicz, Karol Wolosewicz, Mikolaj Chrominski, Jacek Jemielity, Joanna Kowalska, Marek R. Baranowski, Ryszard Lazny

  • Open Access

    In Situ Infrared and Raman Analysis of Structural Changes of (C 60 Pd 3 ) n Coordination Polymer under Elevated Pressure

    by Sylwia ZięBa, Emilia Grądzka, Adam Mizera, Dariusz Pogocki, Barbara Seroka, Jakub Goclon, Ryszard Łaźny, Krzysztof Winkler

    Structural changes of a fullerene–palladium (C60Pd3) coordination polymer under increased pressure conditions were monitored via in situ infrared and Raman spectroscopy. The body-centered cubic structure of the fullerene-based coordination polymer could be transferred to the amorphous (C60)n homofullerene polymeric phase under a mild pressure of ∼4.5 GPa. This phase was formed by C60Pd3 under considerably milder pressure conditions than C60 polymerization that required higher pressure. Analogous investigations performed with C60[η2-Pd(PPh3)2] complex did not form the (C60)n homofullerene polymeric phase. The transformation of C60Pd3 to an amorphous homofullerene polymer phase was possibly because of the formation of metallic palladium nanocrystals and a local pressure increase, resulting in the formation of (C60)n. Additional theoretical calculations showed that pressure strongly influenced the bonding of fullerene moieties in the presence of palladium clusters. This effect was particularly significant in the case of C60 moiety linked through palladium atoms.


  • Therapeutic potential of bile acids and synthetic strategies of their incorporation into polymeric drug delivery systems

    by Dawid Szymczuk, Agnieszka Z. Wilczewska, Katarzyna Niemirowicz-Laskowska, Pawel Misiak, Ryszard Lazny, Karolina H. Markiewicz

    This review discusses the bioactivity of bile acids and the synthetic strategies used to integrate them into polymers to create drug delivery systems with enhanced therapeutic performance.


  • Open Access

    Design, Synthesis, and Biological Evaluation of Novel Acetylcholinesterase and β-Secretase 1 Inhibitors

    by Danuta Drozdowska, Damian Pawelski, Agnieszka Wróbel-Tałałaj, Marta Plonska-Brzezinska, Beata Kolesinska, Ryszard Lazny, Barbara Seroka, Cezary Parzych, Artur Ratkiewicz

    A series of novel granatane–triazole hybrid molecules was designed, synthesized, and evaluated as dual acetylcholinesterase (AChE) and β-secretase 1 (BACE1) inhibitors. The compounds were obtained through a convergent synthetic route involving azide formation, triazole construction via dipolar cycloaddition, and final coupling with a granatane scaffold to give a pseudopelletierine (3-granatanone) analogue. In vitro assays demonstrated that all target compounds inhibited both AChE and BACE1. Molecular docking and molecular dynamics simulations revealed stable interactions with key catalytic residues, suggesting distinct binding modes compared to reference ligands. QSAR-based pharmacokinetic predictions indicated favorable blood–brain barrier permeability and compliance with key drug-likeness filters. These findings identify granatane–triazole hybrids as promising multi-target directed ligand (MTDL) candidates with potential for further optimization in the search for new anti-Alzheimer therapeutics.

  • Open Access

    Folic-Acid-Conjugated Thermoresponsive Polymeric Particles for Targeted Delivery of 5-Fluorouracil to CRC Cells

    by Sylwia Milewska, Gabriela Siemiaszko, Agnieszka Zofia Wilczewska, Iwona Misztalewska-Turkowicz, Karolina Halina Markiewicz, Dawid Szymczuk, Diana Sawicka, Halina Car, Ryszard Lazny, Katarzyna Niemirowicz-Laskowska

    Colorectal cancer is the fourth most common cancer worldwide and the third most frequently diagnosed form of cancer associated with high mortality rates. Recently, targeted drug delivery systems have been under increasing attention owing to advantages such as high therapeutic effectiveness with a significant depletion in adverse events. In this report, we describe the biocompatible and thermoresponsive FA-conjugated PHEA-b-PNIPAAm copolymers as nanocarriers for the delivery of 5-FU. The block copolymers were obtained using RAFT (Reversible Addition–Fragmentation chain Transfer) polymerization and were characterized by methods such as SEC (Size Exclusion Chromatography), NMR (Nuclear Magnetic Resonance), UV–Vis (Ultraviolet–Visible), FT-IR (Fourier Transform Infrared) spectroscopy, and TGA (Thermogravimetric Analysis). Nanoparticles were formed from polymers with and without the drug-5-fluorouracil, which was confirmed using DLS (Dynamic Light Scattering), zeta potential measurements, and TEM (Transmission Electron Microscopy) imaging. The cloud points of the polymers were found to be close to the temperature of the human body. Eventually, polymeric carriers were tested as drug delivery systems for the safety, compatibility, and targeting of colorectal cancer cells (CRC). The biological evaluation indicated high compatibility with the representative host cells. Furthermore, it showed that proposed nanosystems might have therapeutic potential as mitigators for 5-FU-induced monocytopenia, cardiotoxicity, and other chemotherapy-associated disorders. Moreover, results show increased cytotoxicity against cancer cells compared to the drug, including a line with a drug resistance phenotype. Additionally, the ability of synthesized carriers to induce apoptosis and necrosis in treated CRC cells has been confirmed. Undoubtedly, the presented aspects of colorectal cancer therapy promise future solutions to overcome the conventional limitations of current treatment regimens for this type of cancer and to improve the quality of life of the patients.


  • Retro-aza-Michael reaction in continuous flow. Approaches to synthesis of adaline and euphococcinine related products

    by Michal Sienkiewicz, Damian Pawelski, Katarzyna Podgorska, Ryszard Lazny


  • Open Access

    Mechanistic details of the actinobacterial lyase-catalyzed degradation reaction of 2-hydroxyisobutyryl-CoA

    by Michael Zahn, Gerhard König, Huy Viet Cuong Pham, Barbara Seroka, Ryszard Lazny, Guangli Yang, Ouathek Ouerfelli, Zenon Lotowski, Thore Rohwerder


  • Open Access

    Monocarbonyl Analogs of Curcumin Based on the Pseudopelletierine Scaffold: Synthesis and Anti-Inflammatory Activity

    by Damian Pawelski, Alicja Walewska, Sylwia Ksiezak, Dariusz Sredzinski, Piotr Radziwon, Marcin Moniuszko, Ramesh Gandusekar, Andrzej Eljaszewicz, Ryszard Lazny, Krzysztof Brzezinski, et al.

    Curcumin (CUR) is a natural compound that exhibits anti-inflammatory, anti-bacterial, and other biological properties. However, its application as an effective drug is problematic due to its poor oral bioavailability, solubility in water, and poor absorption from the gastrointestinal tract. The aim of this work is to synthesize monocarbonyl analogs of CUR based on the 9-methyl-9-azabicyclo[3.2.1]nonan-3-one (pseudopelletierine, granatanone) scaffold to improve its bioavailability. Granatane is a homologue of tropane, whose structure is present in numerous naturally occurring alkaloids, e.g., l-cocaine and l-scopolamine. In this study, ten new pseudopelletierine-derived monocarbonyl analogs of CUR were successfully synthesized and characterized by spectral methods and X-ray crystallography. Additionally, in vitro test of the cytotoxicity and anti-inflammatory properties of the synthesized compounds were performed.


  • Open Access

    Curcumin and Its New Derivatives: Correlation between Cytotoxicity against Breast Cancer Cell Lines, Degradation of PTP1B Phosphatase and ROS Generation

    by Tomasz Kostrzewa, Karol Wołosewicz, Marek Jamrozik, Joanna Drzeżdżon, Julia Siemińska, Dagmara Jacewicz, Magdalena Górska-Ponikowska, Marcin Kołaczkowski, Ryszard Łaźny, Alicja Kuban-Jankowska

    Breast cancer is the most common cancer of women—it affects more than 2 million women worldwide. PTP1B phosphatase can be one of the possible targets for new drugs in breast cancer therapy. In this paper, we present new curcumin derivatives featuring a 4-piperidone ring as PTP1B inhibitors and ROS inducers. We performed cytotoxicity analysis for twelve curcumin derivatives against breast cancer MCF-7 and MDA-MB-231 cell lines and the human keratinocyte HaCaT cell line. Furthermore, because curcumin is a known antioxidant, we assessed antioxidant effects in its derivatives. For the most potent cytotoxic compounds, we determined intracellular ROS and PTP1B phosphatase levels. Moreover, for curcumin and its derivatives, we performed real-time microscopy to observe the photosensitizing effect. Finally, computational analysis was performed for the curcumin derivatives with an inhibitory effect against PTP1B phosphatase to assess the potential binding mode of new inhibitors within the allosteric site of the enzyme. We observed that two tested compounds are better anticancer agents than curcumin. Moreover, we suggest that blocking the -OH group in phenolic compounds causes an increase in the cytotoxicity effect, even at a low concentration. Furthermore, due to this modification, a higher level of ROS is induced, which correlates with a lower level of PTP1B.